Lesion network mapping
From Wikipedia, the free encyclopedia
Lesion network mapping is a neuroimaging technique that analyzes the connectivity pattern of brain lesions to identify neuroanatomic correlates of symptoms.[1][2][3] The scientific validity of these methods has been widely disputed.[4][5][6] The technique was developed by Aaron Boes to understand the network anatomy of lesion induced neurologic and psychiatric symptoms that can not be explained by focal anatomic localization.[7][8] Lesion network mapping applies a network-based approach to identify connected brain networks, rather than focal brain regions, that correlate with a specific symptom.
In focal neuroanatomic localization, developed by Paul Broca and others, specific symptoms that occur due to brain lesions can be understood by identifying a specific brain region that is injured by lesions to establish brain-symptom relationships.[2] However, a number of neurologic symptoms, such as peduncular hallucinosis, are not amenable to this approach since the lesions associated with the symptom do not map to one focal brain location.[1] Lesion network mapping helps to explain these lesion-induced syndromes by showing that lesion locations associated with a given symptom all map to a shared brain network even if they do not all map to a focal brain region.[2] The technique maps the location of lesions associated with a specific symptom and analyzes the connectivity pattern of the lesions compared to large, standardized human brain atlases. While initially developed using resting-state fMRIs such as the Human Connectome Project,[1] the technique has been expanded to include large structural network atlases [9] and multimodal-connectome datasets.[10] Software tools for that facilitate lesion network mapping exist within the Lead-DBS framework,[11] which is also used for a related technique, DBS network mapping.
Lesion network mapping has helped map the network anatomy of numerous rare neurologic syndromes (peduncular hallucinosis,[1] delusional misidentification,[12] reduplicative paramensia,[13] akinetic mutism,[14] blindsight,[15] visual anosognosia[16]), common neurologic syndromes (seizures,[17] aphasia,[18] amnesia,[19] parkinsonism,[20] topographical disorientation[21]), psychiatric syndromes[22] (depression,[23][24] mania[25]), as well as complex human behaviors (spirituality,[26] religious fundamentalism,[27] consciousness,[28][29] free will,[14] criminality,[30] addiction[31]). The technique has been successfully applied to a broad range of diseases and lesion types including lesions due to stroke,[1] traumatic brain injury,[26] tuberous sclerosis[32][33] and multiple sclerosis.[34][35] The technique has been broadened to map the connectivity of locations from transcranial magnetic stimulation[24] and deep brain stimulation[36] sites to understand treatment responsiveness.
Research findings based on lesion network mapping have been reported in the New York Times,[37] Scientific American[38] and USA Today[39] and the term has been included in the New England Journal of Medicine's general medical glossary.[3]